Literature DB >> 20335652

Pathogen-specific antibodies: codependent no longer.

Edward N Janoff1, Daniel N Frank.   

Abstract

Antibody-mediated defense against pathogens typically requires complex interactions between antibodies and other constituents of the humoral and cellular immune systems. However, recent evidence indicates that some antibodies alone can inhibit pathogen function in the absence of complement, phagocytes, or NK cells. In this issue of the JCI, McClelland et al. have begun to elucidate the molecular bases by which antibodies alone can impact pathogen growth and metabolism. They show that mAbs specific for the polysaccharide capsule of the human pathogenic fungus Cryptococcus neoformans elicit diverse effects on fungal gene expression, lipid biosynthesis, susceptibility to amphotericin B, cellular metabolism, and protein phosphorylation. These data suggest that pathogens have the capacity to generate broad metabolic responses as a result of surface binding by pathogen-specific antibodies, effects that may hold therapeutic promise.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20335652      PMCID: PMC2846075          DOI: 10.1172/JCI42695

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  18 in total

1.  Ab binding alters gene expression in Cryptococcus neoformans and directly modulates fungal metabolism.

Authors:  Erin E McClelland; André M Nicola; Rafael Prados-Rosales; Arturo Casadevall
Journal:  J Clin Invest       Date:  2010-03-24       Impact factor: 14.808

2.  Variations in the ospB gene of Borrelia burgdorferi result in differences in monoclonal antibody reactivity and in production of escape variants.

Authors:  J L Coleman; R C Rogers; P A Rosa; J L Benach
Journal:  Infect Immun       Date:  1994-01       Impact factor: 3.441

Review 3.  Deciphering the model pathogenic fungus Cryptococcus neoformans.

Authors:  Alexander Idnurm; Yong-Sun Bahn; Kirsten Nielsen; Xiaorong Lin; James A Fraser; Joseph Heitman
Journal:  Nat Rev Microbiol       Date:  2005-10       Impact factor: 60.633

4.  Selection of an escape variant of Borrelia burgdorferi by use of bactericidal monoclonal antibodies to OspB.

Authors:  J L Coleman; R C Rogers; J L Benach
Journal:  Infect Immun       Date:  1992-08       Impact factor: 3.441

5.  Characterization of the physiological requirements for the bactericidal effects of a monoclonal antibody to OspB of Borrelia burgdorferi by confocal microscopy.

Authors:  R Escudero; M L Halluska; P B Backenson; J L Coleman; J L Benach
Journal:  Infect Immun       Date:  1997-05       Impact factor: 3.441

6.  A randomized, blinded, multicenter trial of lipid-associated amphotericin B alone versus in combination with an antibody-based inhibitor of heat shock protein 90 in patients with invasive candidiasis.

Authors:  Jan Pachl; Petr Svoboda; Frédérique Jacobs; Koenraad Vandewoude; Ben van der Hoven; Peter Spronk; Gary Masterson; Manu Malbrain; Mickael Aoun; Jorge Garbino; Jukka Takala; Lubos Drgona; James Burnie; Ruth Matthews
Journal:  Clin Infect Dis       Date:  2006-04-12       Impact factor: 9.079

Review 7.  Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS.

Authors:  Benjamin J Park; Kathleen A Wannemuehler; Barbara J Marston; Nelesh Govender; Peter G Pappas; Tom M Chiller
Journal:  AIDS       Date:  2009-02-20       Impact factor: 4.177

Review 8.  Cryptococcosis in solid organ transplant recipients: current state of the science.

Authors:  Nina Singh; Francoise Dromer; John R Perfect; Olivier Lortholary
Journal:  Clin Infect Dis       Date:  2008-11-15       Impact factor: 9.079

9.  Generation of a complement-independent bactericidal IgM against a relapsing fever Borrelia.

Authors:  Sean E Connolly; David G Thanassi; Jorge L Benach
Journal:  J Immunol       Date:  2004-01-15       Impact factor: 5.422

10.  A bactericidal antibody to Borrelia burgdorferi is directed against a variable region of the OspB protein.

Authors:  A Sadziene; M Jonsson; S Bergström; R K Bright; R C Kennedy; A G Barbour
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

View more
  2 in total

1.  Paucity of initial cerebrospinal fluid inflammation in cryptococcal meningitis is associated with subsequent immune reconstitution inflammatory syndrome.

Authors:  David R Boulware; Shulamith C Bonham; David B Meya; Darin L Wiesner; Gregory S Park; Andrew Kambugu; Edward N Janoff; Paul R Bohjanen
Journal:  J Infect Dis       Date:  2010-09-15       Impact factor: 5.226

2.  B Cell Compartmentalization in Blood and Cerebrospinal Fluid of HIV-Infected Ugandans with Cryptococcal Meningitis.

Authors:  Samuel Okurut; David B Meya; Freddie Bwanga; Joseph Olobo; Michael A Eller; Fatim Cham-Jallow; Paul R Bohjanen; Harsh Pratap; Brent E Palmer; Katharine H Hullsiek; Yukari C Manabe; David R Boulware; Edward N Janoff
Journal:  Infect Immun       Date:  2020-02-20       Impact factor: 3.441

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.